National Institutes of Health · Department of Health and Human Services
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
Key facts
- Deadline
- Forecast — the expected date (Sep 30, 2026) has passed; watch for the official notice
- Award size
- Not specified — see notice
- Cost share / match ?
- Not required · Work out your budget and match
- Who can apply
- County government, Other (see eligibility), Small business, Special district (utility, fire, etc.), Tribal organization, Private college or university, State government, Larger business, Tribal government, Public college or university, City or town government, Nonprofit with 501(c)(3), Nonprofit without 501(c)(3), School district
- Where
- Anywhere in the U.S., including Tennessee
Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Grant-ready checklist
How this fits you
- Available in Henry County (nationwide program)
- No cost share required
- Tennessee recipients since 2023: 19
Tell us who you are to see whether you're eligible.
More from National Institutes of Health
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) · Forecast — the expected date (Jul 15, 2025) has passed; watch for the official notice
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) · Forecast — the expected date (Jul 15, 2025) has passed; watch for the official notice
- Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research Centers · Forecast — the expected date (Jul 25, 2025) has passed; watch for the official notice
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) · Forecast — the expected date (Aug 22, 2025) has passed; watch for the official notice
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed) · Forecast — the expected date (Sep 30, 2025) has passed; watch for the official notice
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed) · Forecast — the expected date (Sep 30, 2025) has passed; watch for the official notice
Official notice: https://simpler.grants.gov/opportunity/ff51d466-1c4b-48d9-a9d1-a860e5415de1 · Printed from grantme.click/grants/ceb5d27b-89a6-4397-b313-c28a5da97636
Read the official notice View on Grants.gov Sign in to save
About this grant
The National Institute of Neurological Disorders and Stroke, National Institute of Aging, the NIH Helping to End Addiction Long Term (HEAL) initiative, and other participating NIH Institutes/Centers (ICs) seek to support applications to develop in vitro, ex vivo or in vivo assays and conduct screening efforts with the goal of identifying and characterizing potential therapeutic agents for disorders or diseases supported by participating ICs, or for non-opioid analgesic therapeutics with little or no addiction liability as a part of the NIH Helping to End Addiction Long Term (HEAL) initiative. Therapeutic agents include small molecules and biologics. Assays utilizing New Approach Methodologies (NAMs) may be used when appropriate.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
Eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Should we apply? (2-minute check) Ask a partner for a letter
Writing the need statement? Henry County facts with citations.
Who in Tennessee has won this program
19 awards to Tennessee recipients in 2 counties since federal FY2023 · 0 in Henry County. Largest shown:
| Recipient | Where | Amount | FY |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville, Davidson County | $7.6M | 2012 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $7.1M | 2017 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $5.3M | 2016 |
| University Of Tennessee | Memphis, Shelby County | $5.3M | 2002 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $5.2M | 1998 |
| Vanderbilt University | Nashville, Davidson County | $4.7M | 2001 |
| Vanderbilt University | Nashville, Davidson County | $4.6M | 2016 |
| Vanderbilt University | Nashville, Davidson County | $4.1M | 1993 |
| Vanderbilt University | Nashville, Davidson County | $3.9M | 2022 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $3.8M | 2021 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $3.7M | 2017 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $3.7M | 2011 |
Source: USAspending.gov. Past awards show who this program funds; they don't guarantee future awards.
About the program (93.853)
Extramural Research Programs in the Neurosciences and Neurological Disorders
How applications are judged
The major elements in evaluating proposals include assessments of: (1) the scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) the soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) the degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...
Matching requirements
This program has no statutory formula.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Examples of funded projects
Not Applicable.